GREAT CARE FOR LITTLE KIDNEYS. EVERYWHERE.
Bayer
At Bayer, we believe it’s possible to create a better world. One where health and nutrition can be made available to all. One where science and innovation can help people and the planet thrive.
Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. We design our products and services to help tackle some of the world’s biggest challenges, and to serve the most essential human needs of health and nutrition.
At Bayer, we’re committed to driving sustainable development and generating a positive impact with our businesses.
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Our purpose is reimagine medicine to improve and extend people’s lives.
Otsuka
At our core is perseverance–a fierce determination to overcome any obstacle, regardless of setbacks, on behalf of patients, caregivers, and their loved ones. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear. Otsuka-people: creating new products for better health worldwide.
Roche
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world.
Sobi
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases.
Inspired by caring, powered by science, we are dedicated to:
Vera Therapeutics
Our mission is to change the standard of care for patients with immunologic and rare diseases. We are developing multiple novel biologic molecules toward this end.
Our lead late-stage clinical candidate is atacicept:
Vertex
We strike at the core of serious diseases to change people’s lives. Bringing together the brightest minds, investing in science and taking smart risks, we go all in. For the lives we have changed and for those who are still waiting, we will never stop fighting until we discover cures.
We have research and development sites and commercial offices around the world, all dedicated to bringing the next transformative treatments to people with serious diseases. Our headquarters are in Boston and London.
We’re happy to announce that you can download our free app from now on.
